Trikafta 100/50/75 — supply status, manufacturers & alternatives

Trikafta 100/50/75

—

🇦🇺 AUST R 330423 · Vertex Pharmaceuticals Australia Pty Ltd

In supply · Australia

In supply · 🇦🇺 Australia · short in🇳🇿 NZ

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Trikafta 100/50/75
Therapeutic category	Auto-created by Medsafe — Product Recalls (New Zealand) scraper
Controlled substance	No

Registrations on file	2

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Recalls official enforcement reports

🇳🇿

Trikafta 100/50/75

Patheon Pharmaceuticals Inc · Aug 2022

Class Idetails ↗

🇳🇿

Trikafta 100/50/75

Patheon Pharmaceuticals Inc · July 2021

Class IIIdetails ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders2 registrations · 1 MA holder

Product	Strength	Form	Market	MA holder	Status
Trikafta	100mg	—	🇦🇺 AU	Vertex Pharmaceuticals Australia Pty Ltd	Active
Trikafta	75 G	—	🇦🇺 AU	Vertex Pharmaceuticals Australia Pty Ltd	Active

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.